International Trade Bulletin - Volume 1, Issue 3
Client Alert | 1 min read | 04.18.06
Inside this issue:
- EUROPE IN THE SPOTLIGHT
- CUSTOMS: Origin rules create risks as well as opportunities
- AVIATION: Huge fines in QRS-11 sensor cases underscore importance of properly classifying exports
- EXPORT CONTROLS: The U.S. continues to assert jurisdiction over re-exports of U.S.-made content in non-U.S. made components
- INTELLECTUAL PROPERTY: Revised International Trademark Law Treaty Adopted
- CHINA: Recent Intellectual Property Rights (IPR) Enforcement-related Developments in China
- BILATERAL TRADE: American investors conducting business in Uruguay may soon have an additional source of protection for their foreign investments
- SANCTIONS: Cuban embargo enforcement lands Sheraton in violation of Mexican Law
Contacts
Insights
Client Alert | 2 min read | 09.18.25
On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”
Client Alert | 3 min read | 09.17.25
Client Alert | 4 min read | 09.17.25
Client Alert | 5 min read | 09.16.25
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today
